Topical steroids and UV radiation in psoriasis

Petrozzi, J. W.

doi:10.1001/archderm.119.3.207

Cited by 12 publications

(10 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…UVB (broadband) A total of six studies fulfilled the criteria for inclusion in the guidelines of which two were assigned a grade of evidence of A2 216,217 and four a grade of evidence of B 218–221 . The A2 studies with conflicting results investigated the combination of UVB with topical therapy in which one arm each investigated UVB with placebo.…”

mentioning

confidence: 99%

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris

Pathirana¹,

Ormerod²,

Saïag³

et al. 2009

Acad Dermatol Venereol

613

892

View full text Add to dashboard Cite

mentioning

confidence: 99%

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris

Pathirana¹,

Ormerod²,

Saïag³

et al. 2009

Acad Dermatol Venereol

613

892

View full text Add to dashboard Cite

“…A synergistic effect of oral NSAID and topical corticosteroids has been reported in the setting of a UV burn; 40 however, the need for the NSAID component to be administered early has limited their clinical application. Alternatives, such as oral terfenadine, 41 oral vitamin E, 42 oral betacarotene, 43 and oral and topical corticocorticoids 44–46 are not shown to be effective in treating phototherapy burns. Current treatment recommendations are largely supportive, and include the use of bland emollients, cool compresses and adequate pain control 47…”

Section: Discussionmentioning

confidence: 99%

Survey of phototherapy practice by dermatologists in Australia

2002

View full text Add to dashboard Cite

A postal survey was sent to all dermatologists in Australia to determine current phototherapy practices. Questionnaires were returned by 158 (57%) of 277 dermatologists, of whom 112 (71%) provided phototherapy. Large variations existed in attitudes and practice, including indications, contraindications, dosage schedules, equipment maintenance, response to adverse events, and follow-up arrangements. Cumulative ultraviolet (UV) doses for psoralen and UVA (PUVA) were not calculated by 21%, while 30% did not calculate cumulative doses for UVB. Written informed consent was not obtained by 32%. Phototherapist dermatologists reported 25 patients developing melanoma following PUVA. Only 30% of Australian dermatologists organize regular follow up of patients after phototherapy. Australians have the highest rates of melanoma and non-melanoma skin cancers in the world, because of their ancestry and high solar exposure. This makes it inappropriate for Australian dermatologists to rely entirely on foreign safety data when assessing the risks and benefits of phototherapy in Australian patients. There is a need for standardized Australian guidelines that can be prospectively assessed to ensure phototherapy is used to maximize efficacy and minimize risks in Australian patients, given their unique ancestral mix and outdoor lifestyle.

show abstract

“…Studies on broadband UVB reported the results of two [181], three [182–186], five [187, 188], and seven [189] exposures weekly. The proportion of patients who achieved a ≥75% improvement varied among included studies.…”

Section: Phototherapymentioning

confidence: 99%

S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update

Nast

Boehncke

Mrowietz

et al. 2012

J Deutsche Derma Gesell

249

247

View full text Add to dashboard Cite

Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, surveys have shown that patients still do not received optimal treatments. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologi sche Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence-based guidelines for the management of psoriasis. They were first published in 2006 and updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate and severe plaque-type psoriasis in adults including systemic therapy, UV therapy and topical therapies. The therapeutic recommendations were developed based on the results of a systematic literature search and were finalized during a consensus meeting using structured consensus methods (nominal group process).

show abstract

Topical steroids and UV radiation in psoriasis

Cited by 12 publications

References 0 publications

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris

Survey of phototherapy practice by dermatologists in Australia

S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update

Contact Info

Product

Resources

About